Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2010
03/10/2010EP1460998B1 Extended release pharmaceutical tablet of metformin
03/10/2010CN101668519A Polymer-based films and drug delivery systems made therefrom
03/10/2010CN101668518A a lactase formulation
03/10/2010CN101668517A Oral controlled release compositions comprising vitamin d compound and waxy carrier
03/10/2010CN101668516A Improved vitamin d content uniformity in pharmaceutical dosage forms
03/10/2010CN101668515A Pharmaceutical composition and process
03/10/2010CN101668514A highly concentrated insulin solutions and compositions
03/10/2010CN101668513A Method of determining the weight of the coating to be applied to form a controlled release dosage form
03/10/2010CN101668512A Controlled release of actives in skin
03/10/2010CN101668511A methods and compositions for normalizing meibomian gland secretions
03/10/2010CN101664411A Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative
03/10/2010CN101664396A Azithromycin soft capsules and preparation method thereof
03/10/2010CN101664395A Method for producing roxithromycin capsules
03/10/2010CN101664394A Tacrolimus sustained-release preparation and preparation method thereof
03/10/2010CN101664393A Methylsulfonic acid pridinol oral disintegrating tablet and preparation method thereof
03/10/2010CN101664392A Gentamycin sulfate tablets and preparation method thereof
03/10/2010CN101664391A Nelarabine freeze-drying powder needle preparation and preparation method thereof
03/10/2010CN101664390A Preparation method of prostaglandin E1
03/10/2010CN101664389A Preparation method of small unilamellar vesicle liposome of ivermectin
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/10/2010CN101664387A Preparation of ether liposome and anti-influenza application
03/10/2010CN101664386A Enrofloxacin double emulsion for livestock and preparation method thereof
03/10/2010CN101664385A Ibutilide fumarate injection and preparation method thereof
03/10/2010CN101664384A N-acetyl-cysteine salt xylitol injection, preparation method and application thereof
03/10/2010CN101664383A Abamectin injection for livestock and preparation method thereof
03/10/2010CN101664382A Novel application of compound betamethasone injection
03/10/2010CN101664381A Preparation method of in-situ gel sustained-release preparation for treating Bovine mastitis
03/10/2010CN101664380A Method for preparing hydrophobic drug nanofibre felty solid dispersion by high-voltage electrostatic spinning
03/10/2010CN101664379A Salicylic acid gelling agent and preparation method thereof
03/10/2010CN101664378A Medical composition of recombinant human serum albumin and interferon alpha fusion protein
03/10/2010CN101664377A Nicardipine sustained release preparation and preparation method thereof
03/10/2010CN100593418C Spray for treating burn
03/10/2010CN100593399C Blood caring soft capsule and preparation process thereof
03/10/2010CN100593398C Film-shaped, dissolvable preparations for active substance release and method for the production thereof
03/09/2010US7674921 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts
03/09/2010US7674875 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation
03/09/2010US7674790 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
03/09/2010US7674767 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate
03/09/2010US7674496 Method for making granules
03/09/2010US7674480 Oral administering; Parkinson's dosease; hyperactivity; attention deficit disorder; using methylphenidate
03/09/2010US7674479 Sustained-release bupropion and bupropion/mecamylamine tablets
03/09/2010US7674478 Polymer micelle as monolayer or layer-laminated surface
03/09/2010US7674477 orthopedic implants
03/09/2010US7674476 Use of aerogels in agriculture
03/09/2010US7674475 Mixture of moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silica, surfactants and oil; veterinary medicine
03/09/2010US7674471 Topical composition, topical composition precursor, and methods for manufacturing and using
03/09/2010US7674396 gastric device having a pouch formed from a gas producing degradable film; gastric devices occupy space in the stomach cavity and reduce the amount of food the patient will ingest before reaching the feeling of fullness; can reside in the stomach for a controlled and prolonged period of time
03/09/2010US7674250 Methods of delivering therapeutic agents
03/09/2010CA2534268C Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same
03/09/2010CA2532803C A composition of matter comprising particles which contain choline chloride to be administered in a rumen protect and post-ruminally effective form
03/09/2010CA2472449C Pharmaceutical composition for oral use with improved absorption
03/09/2010CA2462457C Sanitary napkins with hydrophobic lotions
03/09/2010CA2432279C Preparation of microparticles having improved flowability
03/09/2010CA2424346C Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
03/09/2010CA2420495C A novel cationic lipopolymer as biocompatible gene delivery agent
03/09/2010CA2411922C Composition for pain mediation and apparatus and method of use thereof
03/09/2010CA2389922C Amphiphilic networks, implantable immunoisolatory devices, and methods of preparation
03/09/2010CA2388395C Compound
03/09/2010CA2349696C Controlled release formulation for water soluble drugs
03/09/2010CA2327655C Tablet production method and tablet
03/09/2010CA2312842C Taurine derivatives useable in the treatment of ophthalmic disorders
03/04/2010WO2010025435A2 Controlled-released peptide formulations
03/04/2010WO2010025349A1 Modified release composition of levetiracetam and process for the preparation thereof
03/04/2010WO2010025324A2 Nanoparticles for immunotherapy
03/04/2010WO2010025322A2 Magnetic nanodelivery of therapeutic agents across the blood brain barrier
03/04/2010WO2010025251A2 Materials and methods for modulating appetite, weight gain and adhd using varenicline
03/04/2010WO2010025126A1 Rapidly disintegrating tablets comprising lipase, amylase, and protease
03/04/2010WO2010024770A1 Wet granulation system comprising at least one ultrasonic nozzle
03/04/2010WO2010024702A2 Pharmaceutical composition for the treatment of periodontal diseases
03/04/2010WO2010024615A2 Method for manufacturing sustained release microsphere by solvent flow evaporation method
03/04/2010WO2010024576A2 Sustained release tablet containing talniflumate with enhanced body absorption
03/04/2010WO2010023908A1 Nanocapsules containing indomethacin and manufacturing method therefor
03/04/2010WO2010023874A1 Film preparation containing loperamide hydrochloride
03/04/2010WO2010023693A2 Novel controlled release compositions of ropinirole
03/04/2010WO2010023689A2 Microparticles
03/04/2010WO2010023505A1 Coated particles of n-acetyl-3-mercaptoalanine with sweeteners
03/04/2010WO2010023321A1 Liquid formulation containing a taxane derivative
03/04/2010WO2010023170A1 Dosage form comprising 1-isopropyl-4-{[4-(tetrahydro-2H-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine or a salt thereof
03/04/2010WO2010022944A1 Pharmaceutical pellet
03/04/2010WO2010022581A1 Medical composition for treating hyperuricemia and the use thereof
03/04/2010WO2010022580A1 Medical composition for treating hyperuricemia and the use thereof
03/04/2010WO2010022568A1 A medication for use in abstinence of drugs and preparation thereof
03/04/2010WO2010022525A1 Emulsion preconcentrates and micellar formulations comprising glyceryl fatty acid esters
03/04/2010WO2010022524A1 Emulsion preconcentrates, and micellar formulations comprising cyclodextrin
03/04/2010WO2010022497A1 Method of treating dysglycemia and glucose excursions
03/04/2010WO2010006117A3 Cyclosporin derivatives for treating ocular and dermal diseases and conditions
03/04/2010WO2010004334A3 Whitened exine shells
03/04/2010WO2009158120A3 Stabilized transdermal drug delivery system
03/04/2010WO2009152597A3 Topical use composition for combatting ectoparasites in dogs and cats
03/04/2010WO2009152144A3 All day rhinitic condition treatment regimen
03/04/2010WO2009152070A3 Intradialytic administration of sodium thiosulfate
03/04/2010WO2009151977A8 Biodegradable impact-modified polymer compositions
03/04/2010WO2009149955A3 Method for the selection of a suitable adjuvant for the production of solid dispersions for pharmaceutical formulations
03/04/2010WO2009148245A3 Novel niacin and hmg-coa reductase inhibitor combination formulation
03/04/2010WO2009147492A3 Aqueous solution comprising iodine and potassium iodide as radiologic marker
03/04/2010WO2009140432A3 Micelles for intracellular delivery of therapeutic agents
03/04/2010WO2009139984A3 Treatment of bladder dysfunction using liposomal botulinum toxin
03/04/2010WO2009138198A3 Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders
1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 2991